Medical Condition News

RSS

Radiation responsive molecules derived from horse chestnuts aid cancer imaging

Research at The City College of New York shows that cancer imaging can be simplified by a photonic process utilizing molecules derived from horse chestnuts.

12 Dec 2017

Researchers use new approach to identify casual mechanisms in depression

People with major depressive disorder have alterations in the activity and connectivity of brain systems underlying reward and memory, according to a new study by the University of Warwick.

12 Dec 2017

Retinal diseases could be treated by ophthalmic drops instead of intraocular injections

The Spanish firm Sylentis has developed a compound to treat diseases of the retina, such as age-related macular degeneration and diabetic retinopathy, which will be administered by ophthalmic drops instead of intraocular injections.

12 Dec 2017

Study reveals novel molecular targets to improve chemotherapy’s efficiency against leukemia

Researchers from Instituto de Medicina Molecular João Lobo Antunes have found a mechanism through which certain types of leukemia resist chemotherapy, thus revealing novel molecular targets that may be used to improve the efficiency of this type of treatment.

12 Dec 2017

Study reveals how the body clock and time of day may influence autoimmune conditions

Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.

12 Dec 2017

Researchers reveal pathological mechanisms in congenital myotonic dystrophy

Myotonic dystrophy (DM) is the most common form of genetic muscular dystrophy that begins in adulthood. DM is characterized by progressive muscle wasting and weakness. People with this disorder often have prolonged muscle contractions (myotonic) and are not able to relax certain muscles after use.

12 Dec 2017

Scientists develop new method for more effective photothermal treatment of tumors

Nanorods made of bismuth sulfide kill tumor cells with heat when they are irradiated with near-infrared light. Chinese scientists are now making these weapons more powerful by remodeling the defect state of the nanorod crystal lattice by adding gold nanodots.

12 Dec 2017

Researchers explore neuro-psychological mechanisms behind existential threats

A group of Salzburg-based researchers led by the psychologist Eva Jonas investigates the neuro-psychological mechanisms behind existential threats. What exactly happens in the process between threat and defensive reaction is at the center of an ongoing study funded by the Austrian Science Fund FWF.

12 Dec 2017

New scientific yardstick released to help early detection of Alzheimer's disease

The European Commission's Joint Research Centre released a new scientific yardstick, in the form of a certified reference material, to help early detection of Alzheimer's disease.

12 Dec 2017

Researchers identify promising solution for improving cystic fibrosis treatments

Researchers at the University of Montreal Hospital Research Centre have identified a promising solution to improving treatments offered to patients with cystic fibrosis.

12 Dec 2017

Hidden genes hold blueprints for designing new anti-cancer drugs

New research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.

12 Dec 2017

Newly discovered molecular chaperones may soon be part of therapies for Huntington's disease

Huntington's disease is a neurodegenerative disease. It is always fatal. The disease is caused by a defect in the Huntingtin gene. To this day, no therapy will put a stop to the insidious disintegration of brain cells.

12 Dec 2017

Parkinson's progression delayed through high-intensity exercise, study says

A new phase 2, multi-site trial conducted at the Northwestern Medicine and University of Colorado School of Medicine suggests that for people with early-stage Parkinson's disease, high-intensity exercise three times a week is safe and can delay the worsening of motor symptoms.

12 Dec 2017

High-intensity exercise decreases worsening of motor symptoms in Parkinson's patients

High-intensity exercise three times a week is safe for individuals with early-stage Parkinson's disease and decreases worsening of motor symptoms, according to a new phase 2, multi-site trial led by University of Colorado Anschutz Medical Campus and Northwestern Medicine scientists.

12 Dec 2017

Study finds rural-urban disparities in prevalence of dementia and cognitive impairment among seniors

Americans who live in urban areas tend to be healthier than individuals living in rural settings. While this healthcare disparity has been examined for more than a decade, researchers present the first nationally representative study to find that dementia and cognitive impairment have consistently been more prevalent among rural-dwelling seniors than urban dwelling seniors.

12 Dec 2017

Researchers find new role for SHARPIN protein in melanoma growth

Researchers at Sanford Burnham Prebys Medical Discovery and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex, regulating NFκB and other inflammatory molecules, SHARPIN modulates PRMT5, an epigenetic master switch that controls several proteins linked to melanoma. The research was published in The Journal of Clinical Investigation.

12 Dec 2017

First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes

The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.

12 Dec 2017

Huntington's disease drug clears initial hurdles - raising hopes

Huntington’s disease is a genetic disorder that affects the brain progressively and has no known cure till date. In a breakthrough, the first drug that can target and reduce the cause behind this dreaded disease has been found to be effective, safe and well tolerated in a human clinical trial that was conducted by UCL scientists.

11 Dec 2017

Study: Combination targeted therapy has high response rates in AML patients

Initial findings from a multi-national open-label phase Ib study of inhibitory drug therapy for relapsed or refractory acute myeloid leukemia (AML) have demonstrated a complete response in up to 50 percent patients say researchers at The University of Texas MD Anderson Cancer Center.

11 Dec 2017

Genentech researchers uncover epigenetic regulator of pancreatic cancer cells

Genentech researchers have identified an enzyme that shifts pancreatic cancer cells to a more aggressive, drug-resistant state by epigenetically modifying the cells' chromatin.

11 Dec 2017

Medical Condition News

Radiation responsive molecules derived from horse chestnuts aid cancer imaging

Researchers use new approach to identify casual mechanisms in depression

Retinal diseases could be treated by ophthalmic drops instead of intraocular injections

Study reveals novel molecular targets to improve chemotherapy’s efficiency against leukemia

Study reveals how the body clock and time of day may influence autoimmune conditions

Researchers reveal pathological mechanisms in congenital myotonic dystrophy

Scientists develop new method for more effective photothermal treatment of tumors

Researchers explore neuro-psychological mechanisms behind existential threats

New scientific yardstick released to help early detection of Alzheimer's disease

Researchers identify promising solution for improving cystic fibrosis treatments

Hidden genes hold blueprints for designing new anti-cancer drugs

Newly discovered molecular chaperones may soon be part of therapies for Huntington's disease

Parkinson's progression delayed through high-intensity exercise, study says

High-intensity exercise decreases worsening of motor symptoms in Parkinson's patients

Study finds rural-urban disparities in prevalence of dementia and cognitive impairment among seniors

Researchers find new role for SHARPIN protein in melanoma growth

First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes

Huntington's disease drug clears initial hurdles - raising hopes

Study: Combination targeted therapy has high response rates in AML patients

Genentech researchers uncover epigenetic regulator of pancreatic cancer cells

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News